Description of Collaborative Activity: |
The NIH-FDA communications working group was established to facilitate collaboration and cooperation between NIH research program directors and FDA, to help ensure that NIH grantees will produce evidence that will meet FDA specifications for regulatory action and/or approval for drugs and medical devices. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM |
